Abacus Global purchased 1,310 life insurance policies in 2025, reporting record origination and transaction activity as it expanded its life settlements footprint. The firm said it set new benchmarks across key portfolio metrics, indicating stronger origination platform and consistent deal flow that should support asset growth and revenue potential for ABX.
Scale in life settlements is a multiplier, not a linear benefit: once origination fixed costs and due-diligence infrastructure are built, each incremental policy meaningfully lowers marginal acquisition cost and shortens payback on capital. That creates a two-step re-rating path — first a near-term uplift to realized IRR from tighter origination economics, then a larger multi-quarter rerating if the firm can package policies into fee-bearing securitizations that convert illiquid holdings into recurring-deposit-like revenues. Key tail risks center on underwriting (longevity) and funding. A 1-2 year miss in median mortality timing or a 150–300bp sustained rise in short-term borrowing costs materially compresses IRRs on purchased policies and raises break-evens for new originations; conversely, improving access to low-cost warehouse financing or prime ABS placements can expand equity returns by 300–800bps across a multi-year horizon. Competitive dynamics: incumbents with proprietary origination channels and in-house actuarial models gain a durable advantage — third-party aggregators and boutique originators will face margin pressure and consolidation. Regulators and litigants are a persistent overhang; a regulatory tightening in a single large state or a precedent-setting wrongful-sale case could reset pricing assumptions industry-wide and temporarily freeze ABS markets, creating a 3–9 month liquidity shock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
